间质性肺疾病的分子遗传学研究进展

www.yongyao.net　　2009-9-14 13:46:10　　来源：　　责任编辑：

分享到：

参考文献
[ 1 ] 　于润江. 间质性肺疾病的分类[ J ]. 中华结核和呼吸杂志,2002, 25 (9) : 5162519.
[ 2 ] 　WahidiMM, SpeerMC, SteeleMP, et al. Familial pulmonary fibrosis in the United States[ J ]. Chest, 2002, 121 (3 Supp l) : 30S.
[ 3 ] 　Barth RK, HanchettLA,Baecher2Allan CM. Mapp ing suscep tibilitygenes for the induction of pulmonary fibrosis in mice [ J ]. Chest,2002, 121 (3 Supp l) : 21S.
[ 4 ] 　Molina V,BlankM, Shoenfeld Y, et al. Fibrotic disease [ J ]. Harefuah, 2002, 141 (11) : 9732978.
[ 5 ] 　SelmanM, Pardo A. Idiopathic pulmonary fibrosis: an ep ithelial/ fibroblastic cross2talk disorder[ J ]. Resp ir Res, 2002, 3 (1) : 3.
[ 6 ] 　Strieter RM. Inflammatory mechanisms are not a minor component of the pathogenesis of idiopathic pulmonary fibrosis[ J ]. Am J Resp ir Crit CareMed, 2002, 165 (9) : 120621207.
[ 7 ] 　AwadMR, EI2Gamel A, Hasleton P, et al. Genotyp ic variation in the transforming growth factor2beta1 gene: association with transforming growth factor2beta1 p roduction, fibrotic lung disease, and graft fibrosis after lung transp lantation [ J ]. Transp lantation, 1998,66 (8) : 101421020.
[ 8 ] 　郑悦,康健,侯显明. 用RT2PCR方法动态分析博莱霉素致肺纤维化大鼠TGF2β1 的基因表达[ J ]. 中国医科大学学报, 2001,30 (2) : 94296.
[ 9 ] 　叶旭军,徐启勇,叶燕青. 结缔组织生长因子基因表达与肺纤维化关系初探[ J ]. 武汉大学学报(医学版) , 2004, 25 ( 5 ) :521-523.
[ 10 ] 　Kothapalli D, Grotendorst GR. CTGF modulates cell cyclep rogression in cAMP. Arrested NRK fibroblasts[ J ]. J Cell Physiol, 2000,182 (1) : 119-126.
[ 11 ] 　Matsuse T. Growth factors in the p rocess of inflammation and fibrosis in the lung[ J ]. Nihon Kokyuki Gakkai Zasshi, 1998, 36 ( 5) :413-420.
[ 12 ] 　曾庆富,赵勇,钱仲斐,等. 肺泡II型TGF2β1 和PDGF基因表达及其在肺纤维化中的意义[ J ]. 临床与实验病理学杂志,2001, 17 (1) : 53256.
[ 13 ] 　Chen ES, Greenlee BM,Wills2Karp sM, et al. Attenuation of lunginflammation and fibrosis in interferon2gamma2deficient mice after intratracheal bleomycin[ J ]. Am J Resp ir CellMol Biol, 2001, 24(5) : 5452555.
[ 14 ] 　田桂珍,高占成,徐钰,等. γ干扰素转基因表达对博莱霉素致小鼠肺纤维化的作用[ J ]. 中华结核和呼吸杂志, 2003, 26 ( 5) :2902293.
[ 15 ] 　WhyteM, Hubbard R,Meliconi R, et al. Increased risk of fibrosing alveolitis associated with interleukin21 recep tor antagonist and tumor necrosis factor2alpha gene polymorphisms [ J ]. Am J Resp irCrit CareMed, 2000, 162 (2 Pt 1) : 7552758.
[ 16 ] 　Pantelidis P, Fanning GC,Wells AU, et al. Analysis of tumor necrosis factor2alpha, lymphotoxin2alpha, tumor necrosis factor recep torII, and interleukin26 polymorphisms in patientswith idiopathic pulmonary fibrosis[ J ]. Am J Resp ir Crit Care Med, 2001, 163 ( 6) :143221436.
[ 17 ] 　Renzoni E,Lympany P, Sestini P, et al. Distribution of novel polymorphisms of the interleukin28 and CXC recep tor 1 and 2 genes insystemic sclerosis and cryp togenic fibrosing alveolitis[ J ]. ArthritisRheum, 2000, 43 (7) : 163321640.
[ 18 ] 　HuangM, Sharma S, Zhu LX, et al. IL27 inhibits fibroblast TGFbeta p roduction and signaling in pulmonary fibrosis[ J ]. J Clin Invest, 2002, 109 (7) : 9312937.
[ 19 ] 　Xu Y, RojkindM, CzajaMJ. Regulation of monocyte chemoat2tractant p rotein21 by cytokines and oxygen free radicals in rat hepatic fat2storing cells[ J ]. Gastroenterology, 1996, 110 (6) :187021877.
[ 20 ] 　Zuo F, Kaminski N, Eugui E, et al. Gene exp ression analysis revealsmatrilysin as a key regulator of pulmonary fibrosis in mice and humans [ J ]. Proc Natl Acad Sci USA, 2002, 99 ( 9 ) :
629226297.
[ 21 ] 　Ghosh S,Mendoza T,Ortiz LA, et al. Bleomycin sensitivity of miceexp ressing dominant2negative p53 in the lung ep ithelium[ J ]. Am JResp ir Crit CareMed, 2002, 166 (6) : 8902897.
[ 22 ] 　Hojo S, Fujita J, Yamadori I, et al. Heterogeneous pointmutation of the p53 gene in pulmonary fibrosis [ J ]. Eur Resp ir J, 1998, 12(6) : 140421408.